| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8615699 | Clinical Lymphoma Myeloma and Leukemia | 2018 | 14 Pages |
Abstract
In the revised Dutch CLL guidelines, chemo-immunotherapy is still the cornerstone of CLL treatment with novel targeted drugs for specific risk groups.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Sabina Kersting, Suzanne I.M. Neppelenbroek, Hein P.J. Visser, Michel van Gelder, Mark-David Levin, Rogier Mous, Ward Posthuma, Hanneke M. van der Straaten, Arnon P. Kater,